Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Pazobrite 400 Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Pazopanib (400mg)

Overview Pazobrite 400 Tablet

Sorafenib 400mg tablets function as a protein kinase inhibitor, indicated for kidney cancer and soft-tissue sarcoma treatment. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose may lead to severe adverse effects. Therapeutic benefits may not be apparent immediately; continue treatment unless instructed otherwise by your doctor. Common side effects include diarrhea and hypertension. Your physician may recommend regular blood pressure monitoring. Manage diarrhea with increased fluid intake or consult your doctor if it persists. This medication can lower blood cell counts, increasing infection risk; report fever, flu-like symptoms, or shortness of breath immediately. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of infection-fighting medications before commencing treatment. This medication interacts with many other drugs; disclose all medications to your healthcare provider. Avoid pregnancy during treatment; effective contraception is crucial for both men and women.

Uses of Pazobrite 400 Tablet

Renal cell carcinoma or soft tissue sarcoma.

Major Benefits of Pazobrite 400 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pazobrite 400mg tablets should be taken on an empty stomach.

Common Side effects of Pazobrite 400 Tablet:

  • Headache
  • Nausea
  • Vomiting
  • Musculoskeletal (bone, muscle or joint) pain
  • Fatigue
  • Change in color of hair
  • Diarrhea
  • High blood pressure
  • Decreased appetite
  • Weight loss
  • Taste change
  • Abnormal skin pigmentation
  • Hair discoloration
  • Tumor pain
  • Breathlessness

How to use Pazobrite 400 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pazobrite 400 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Pazobrite 400 Tablet works:

Pazobrite 400mg tablets are an anticancer drug. Their mechanism of action involves targeting and blocking tyrosine kinase enzyme receptors, crucial for cancerous cell multiplication. The medication also prevents the development of new blood vessels supplying the tumor, thus hindering its growth and spread.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Pazobrite 400 Tablet may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Pazobrite 400 Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Nursing mothers should avoid Pazobrite 400 Tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingUNSAFE

Taking Pazobrite 400 Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Pazobrite 400mg tablets can be administered to patients with renal impairment without requiring a modification of the dosage.

LiverLiverCAUTION

Patients with liver impairment should use Pazobrite 400 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Pazobrite 400 Tablets are contraindicated for individuals with moderate to severe hepatic dysfunction.

What if you forget to take Pazobrite 400 Tablet :

NA

Facts to Know About Pazobrite 400 Tablet

LabelValue
Chemical Category Diarylalkylamines
Developing Habits No.
Treatment Category Cancer Medications
Actions Kinase inhibitors targeting tyrosine

FAQs on Pazobrite 400 Tablet

Pazobrite 400 Tablet isn't a standard chemotherapy drug; it's a protein kinase inhibitor. This medication functions by blocking proteins crucial to cancer cell growth and spread.
Take one Pazobrite 400 Tablet orally daily, or as your doctor instructs. Swallow whole with water; do not crush or break the tablet, as this alters absorption and may increase side effects.
Take Pazobrite 400 Tablet on an empty stomach, at least one hour before or two hours after eating. Food may reduce its effectiveness, potentially requiring a higher dose and increasing side effects.
Treatment duration with Pazobrite 400 Tablet is individualized. Your doctor will determine the appropriate length of treatment based on your response and tolerance, so don't discontinue use without consulting them. Continue taking it as directed for as long as it remains effective and well-tolerated.
Yes, avoid grapefruit and grapefruit juice while taking Pazobrite 400 Tablets, as they can interfere with its effectiveness. Consult your doctor about other potential dietary restrictions.
Treatment duration with Pazobrite 400 Tablet is individualized. Your doctor will determine the appropriate length of treatment based on your response and tolerance. Never discontinue use without consulting your doctor. Continue taking it as directed for as long as it remains effective and well-tolerated.
Pazobrite 400 Tablets can cause serious, potentially life-threatening liver damage. Report any history of liver disease to your doctor. Immediately contact your doctor if you experience symptoms like yellowing skin or eyes, dark urine, fatigue, nausea, vomiting, appetite loss, upper right abdominal pain, or unusual bleeding/bruising. Pre-treatment liver tests may be required, followed by tests at weeks 3, 5, 7, and 9, then months 3 and 4, with further testing as deemed necessary by your doctor. Regular monitoring will continue after 4 months.
Pazobrite 400 Tablet
9,005
MRP 10,422
13% off